Inactivated Bivalent Enterovirus Vaccine Phase I/II Clinical Trial: Open-Label Observation in Healthy Adults and Children, and Randomized, Double-Blind, Controlled Clinical Trial in Children
Latest Information Update: 25 Jan 2026
At a glance
- Drugs Bivalent-enterovirus-inactivated-vaccine-Sinovac-Biotech (Primary) ; Enterovirus A vaccine
- Indications Enterovirus A infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sinovac Biotech
Most Recent Events
- 16 Jan 2026 Actual Primary Completion Date is 19 Dec 2025.
- 16 Jan 2026 Planned End Date changed from 10 Apr 2025 to 10 Mar 2026.
- 16 Jan 2026 Status changed from recruiting to active, no longer recruiting.